Invitation to teleconference for analysts, investors and journalists

Presentation of Meda’s First Quarter Results 2014

On Wednesday, May 7th, 2014 at 8:00 CET, Meda will release its first quarter results for 2014. Meda invites all analysts, investors and media to a teleconference to be held on Wednesday, May 7th at 10:30 CET.

During the teleconference, CEO Jörg-Thomas Dierks and CFO Henrik Stenqvist will present the  2014 first quarter report.

The first quarter report will be available at Meda’s website, Slides from the presentation will be available at the same address. The webcast presentation can be heard at:

To participate in the telephone conference, please call:

SE: +46 8 505 56 474

UK: +44 203 364 5374

US: +1 (855)753-2230

For further information, please contact

Paula Treutiger, +46 8 630 2082

MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 120 countries worldwide and the company is represented by its own organizations in over 55 countries. The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. Find out more, visit

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.

Documents & Links